What's in Piramal Imaging Limited's pipeline?

Piramal Imaging Limited has 1 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Piramal Imaging Limited's portfolio?

Top competitors by shared drug class: ABX advanced biochemical compounds GmbH, Central Hospital, Nancy, France, Centre hospitalier de l'Université de Montréal (CHUM), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Institute for Neurodegenerative Disorders.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/piramal-imaging-limited.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Piramal Imaging Limited — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Piramal Imaging Limited pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Neuraceq (florbetaben 18F)	Neuraceq (florbetaben 18F)	marketed	PET imaging agent	Amyloid-beta plaques	Neurology / Diagnostic Imaging

Therapeutic area mix

Neurology / Diagnostic Imaging · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

ABX advanced biochemical compounds GmbH · 1 shared drug class
Central Hospital, Nancy, France · 1 shared drug class
Centre hospitalier de l'Université de Montréal (CHUM) · 1 shared drug class
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · 1 shared drug class
Institute for Neurodegenerative Disorders · 1 shared drug class
OHSU Knight Cancer Institute · 1 shared drug class
SOFIE · 1 shared drug class
Universidad Central del Caribe · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Piramal Imaging Limited:

Cite this brief

Drug Landscape (2026). Piramal Imaging Limited — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/piramal-imaging-limited. Accessed 2026-05-16.